Viewing StudyNCT00228358



Ignite Creation Date: 2024-05-05 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00228358
Status: COMPLETED
Last Update Posted: 2014-11-11
First Post: 2005-09-13

Brief Title: Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patients Own T Cells in the Laboratory in Treating Patients With HER-2Neu Overexpressing Metastatic Breast Cancer Ovarian Cancer or Non-Small Cell Lung Cancer Previously Treated With HER-2Neu Vaccine
Sponsor: University of Washington
Organization: University of Washington

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-06
Start Date Type: None
Primary Completion Date: 2011-05
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2005-09-13
First Submit QC Date: September 26 2005
Study First Post Date: 2005-09-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-11-07
Last Update Post Date: 2014-11-11
Last Update Post Date Type: ESTIMATED